Accessibility: Skip TopNav
Mean Reticulocytes / Mean Total Bilirubin
Apellis Pharmaceuticals Provides Update on Phase 1b Open Label Study of APL-2 in PNH Patients Not Previously Treated with Eculizumab
Format
JPEG
Source
Apellis Pharmaceuticals, Inc.
Downloads
Original
Large
Medium
Small